About this trial
The purpose of the current study is to:
Compare the effect of radiofrequency (TECAR) therapy and ultrasound on sensation, manual dexterity, and quality of life in individuals diagnosed with carpal tunnel syndrome (CTS). The study also correlates sensation, hand dexterity, and quality of life in patients with carpal tunnel syndrome.
Eligibility criteria
Qualifiers
Adults aged 35 to 50 years.
Presence of typical CTS symptoms for at least one month.
Cutoff values of VAS are defined between 35 mm and 64 mm.
Patients were diagnosed with moderate carpal tunnel syndrome clinically by physical examination (positive Phalen's test and Tinel's sign) and confirmed by an electrodiagnostic study (EDX) with a fractionated sensory nerve conduction velocity for the median nerve across the wrist of 40 m/s or less and with sensory distal latency more than 3.6 ms and less than 4 ms and a normal CMAP amplitude in the APB muscle.
Disqualifiers
Severe carpal tunnel syndrome requires surgical intervention.
Presence of systemic diseases associated with CTS, such as diabetes mellitus, rheumatoid arthritis, hypothyroidism, or other inflammatory disorders.
Pregnancy.
History of fractures, trauma, or surgery in the wrist or hand region.
Trial design
Treatments tested in this trial
- Radiofrequency
- Therapeutic Ultrasound
Treatment groups
Sponsors and collaborators
Delta University for Science and Technology
Lead sponsor
Cairo University
Collaborator